Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 177 articles:
HTML format
Text format



Single Articles


    April 2018
  1. VAHATALO I, Ilmarinen P, Tuomisto LE, Niemela O, et al
    Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.
    Respir Med. 2018;137:70-76.
    PubMed     Text format     Abstract available


  2. LIN J, Wang W, Chen P, Zhou X, et al
    Prevalence and risk factors of asthma in mainland China: The CARE study.
    Respir Med. 2018;137:48-54.
    PubMed     Text format     Abstract available


  3. SATIRER O, Mete Yesil A, Emiralioglu N, Tugcu GD, et al
    A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.
    Respir Med. 2018;137:35-39.
    PubMed     Text format     Abstract available


  4. THOMSEN AML, Ehrenstein V, Riis AH, Toft G, et al
    The potential impact of paternal age on risk of asthma in childhood: a study within the Danish National Birth Cohort.
    Respir Med. 2018;137:30-34.
    PubMed     Text format     Abstract available


  5. QU Y, Zhang C, Hu Z, Li S, et al
    The 100 most influential publications in asthma from 1960 to 2017: A bibliometric analysis.
    Respir Med. 2018;137:206-212.
    PubMed     Text format     Abstract available


  6. DY T, Lewis EM, Murugan V, Gehlert S, et al
    Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma.
    Respir Med. 2018;137:201-205.
    PubMed     Text format     Abstract available


  7. WACHTEL H, Nagel M, Engel M, El Azzi G, et al
    In vitro and clinical characterization of the valved holding chamber AeroChamber Plus((R)) Flow-Vu((R)) for administrating tiotropium Respimat((R)) in 1-5-year-old children with persistent asthmatic symptoms.
    Respir Med. 2018;137:181-190.
    PubMed     Text format     Abstract available


  8. KURT OK, Ergun D, Basaran N
    Can the ceramic industry be a new and hazardous sector for work-related asthma?
    Respir Med. 2018;137:176-180.
    PubMed     Text format     Abstract available


    March 2018
  9. BRUMPTON BM, Langhammer A, Henriksen AH, Romundstad PR, et al
    Serum 25-hydroxyvitamin D, vitamin D supplement and asthma control: The HUNT study.
    Respir Med. 2018;136:65-70.
    PubMed     Text format     Abstract available


  10. CIPRANDI G, Schiavetti I, Ricciardolo FLM
    The impact of aging on outpatients with asthma in a real-world setting.
    Respir Med. 2018;136:58-64.
    PubMed     Text format     Abstract available


  11. ZELT JT, Jones JH, Hirai DM, King TJ, et al
    Systemic vascular dysfunction is associated with emphysema burden in mild COPD.
    Respir Med. 2018;136:29-36.
    PubMed     Text format     Abstract available


  12. LISSPERS K, Janson C, Larsson K, Johansson G, et al
    Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR).
    Respir Med. 2018;136:15-20.
    PubMed     Text format     Abstract available


  13. SUAREZ-CUARTIN G, Giner J, Merino JL, Rodrigo-Troyano A, et al
    Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.
    Respir Med. 2018;136:111-117.
    PubMed     Text format     Abstract available


    February 2018
  14. GOULD CF, Perzanowski MS, Evans D, Bruzzese JM, et al
    Association of exercise-induced wheeze and other asthma symptoms with emergency department visits and hospitalizations in a large cohort of urban adolescents.
    Respir Med. 2018;135:42-50.
    PubMed     Text format     Abstract available


  15. MARTINEZ-RIVERA C, Crespo A, Pinedo-Sierra C, Garcia-Rivero JL, et al
    Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Respir Med. 2018;135:22-28.
    PubMed     Text format     Abstract available


  16. VARGAS MH, Becerril-Angeles M, Medina-Reyes IS, Rascon-Pacheco RA, et al
    Altitude above 1500m is a major determinant of asthma incidence. An ecological study.
    Respir Med. 2018;135:1-7.
    PubMed     Text format     Abstract available


    January 2018
  17. SUZUKAWA M, Matsumoto H, Ohshima N, Tashimo H, et al
    Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
    Respir Med. 2018;134:95-102.
    PubMed     Text format     Abstract available


  18. KORENBLAT P, Kerwin E, Leshchenko I, Yen K, et al
    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
    Respir Med. 2018;134:143-149.
    PubMed     Text format     Abstract available


  19. HAUGHNEY J, Morice A, Blyth KG, Lee AJ, et al
    A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Respir Med. 2018;134:117-123.
    PubMed     Text format     Abstract available


  20. GAO YH, Liu SX, Cui JJ, Wang LY, et al
    Subclinical atherosclerosis in adults with steady-state bronchiectasis: A case-control study.
    Respir Med. 2018;134:110-116.
    PubMed     Text format     Abstract available


    December 2017
  21. VILMANN L, Buchvald F, Green K, Nielsen KG, et al
    Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children.
    Respir Med. 2017;133:42-47.
    PubMed     Text format     Abstract available


  22. NICHOLSON A, Pollard SL, Lima JJ, Romero KM, et al
    Serum folate concentrations, asthma, atopy, and asthma control in Peruvian children.
    Respir Med. 2017;133:29-35.
    PubMed     Text format     Abstract available


  23. LAWSON JA, Brozek G, Shpakou A, Fedortsiv O, et al
    An international comparison of asthma, wheeze, and breathing medication use among children.
    Respir Med. 2017;133:22-28.
    PubMed     Text format     Abstract available


  24. SZENTPETERY SS, Gruzieva O, Forno E, Han YY, et al
    Combined effects of multiple risk factors on asthma in school-aged children.
    Respir Med. 2017;133:16-21.
    PubMed     Text format     Abstract available


    November 2017
  25. JUDSON MA
    Endpoints in sarcoidosis: More like IPF or asthma?
    Respir Med. 2017 Nov 20. pii: S0954-6111(17)30384.
    PubMed     Text format    


  26. SVEDSATER H, Leather D, Robinson T, Doll H, et al
    Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Respir Med. 2017;132:76-83.
    PubMed     Text format     Abstract available


  27. CONDREAY L, Chiano M, Ortega H, Buchan N, et al
    No genetic association detected with mepolizumab efficacy in severe asthma.
    Respir Med. 2017;132:178-180.
    PubMed     Text format     Abstract available


  28. SUNDH J, Wireklint P, Hasselgren M, Montgomery S, et al
    Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.
    Respir Med. 2017;132:154-160.
    PubMed     Text format     Abstract available


  29. LEE J, Kronborg C, O'Hehir RE, Hew M, et al
    Who's at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic.
    Respir Med. 2017;132:146-148.
    PubMed     Text format     Abstract available


  30. PENG YH, Su SY, Liao WC, Huang CW, et al
    Asthma is associated with endometriosis: A retrospective population-based cohort study.
    Respir Med. 2017;132:112-116.
    PubMed     Text format     Abstract available


  31. BLAIS CM, Davis BE, Cockcroft DW
    Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Respir Med. 2017;132:109-111.
    PubMed     Text format    


  32. MAZENQ J, Dubus JC, Gaudart J, Charpin D, et al
    City housing atmospheric pollutant impact on emergency visit for asthma: A classification and regression tree approach.
    Respir Med. 2017;132:1-8.
    PubMed     Text format     Abstract available


    October 2017
  33. BAKIRTAS A, Kutlu A, Baccioglu A, Erkekol FO, et al
    Physicians' preference for controller medication in mild persistent asthma.
    Respir Med. 2017;131:236-240.
    PubMed     Text format     Abstract available


  34. LI N, Qiu R, Yang Z, Li J, et al
    Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Respir Med. 2017;131:192-198.
    PubMed     Text format     Abstract available


  35. SCHMIDT O, Petro W, Hoheisel G, Kanniess F, et al
    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Respir Med. 2017;131:166-174.
    PubMed     Text format     Abstract available


  36. AGGELOU K, Siafakas N
    Medical lung volume reduction for severe emphysema: A review.
    Respir Med. 2017;131:141-147.
    PubMed     Text format     Abstract available


  37. FITZGERALD JM, Tavakoli H, Lynd LD, Al Efraij K, et al
    The impact of inappropriate use of short acting beta agonists in asthma.
    Respir Med. 2017;131:135-140.
    PubMed     Text format     Abstract available


  38. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    PubMed     Text format     Abstract available


    September 2017
  39. TALINI D, Ciberti A, Bartoli D, Del Guerra P, et al
    Work-related asthma in a sample of subjects with established asthma.
    Respir Med. 2017;130:85-91.
    PubMed     Text format     Abstract available


  40. MANISCALCO M, Zamparelli AS, Vitale DF, Faraone S, et al
    Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study.
    Respir Med. 2017;130:69-74.
    PubMed     Text format     Abstract available


  41. DI BONA D, Fiorino I, Taurino M, Frisenda F, et al
    Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
    Respir Med. 2017;130:55-60.
    PubMed     Text format     Abstract available


  42. COX CA, Boudewijn IM, Vroegop SJ, Schokker S, et al
    Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Med. 2017;130:35-42.
    PubMed     Text format     Abstract available


  43. TANNO LK, Haahtela T, Calderon MA, Cruz A, et al
    Implementation gaps for asthma prevention and control.
    Respir Med. 2017;130:13-19.
    PubMed     Text format     Abstract available


    August 2017
  44. MAHON J, Fitzgerald A, Glanville J, Dekhuijzen R, et al
    Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
    Respir Med. 2017;129:98-116.
    PubMed     Text format     Abstract available


  45. KWON JW, Chang HS, Heo JS, Bae DJ, et al
    Characteristics of asthmatics with detectable IL-32gamma in induced sputum.
    Respir Med. 2017;129:85-90.
    PubMed     Text format     Abstract available


  46. LEWIS A, Torvinen S, Dekhuijzen PNR, Chrystyn H, et al
    Budesonide + formoterol delivered via Spiromax(R) for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler(R).
    Respir Med. 2017;129:179-188.
    PubMed     Text format     Abstract available


    July 2017
  47. NELSEN LM, Vernon M, Ortega H, Cockle SM, et al
    Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.
    Respir Med. 2017;128:42-49.
    PubMed     Text format     Abstract available


  48. SUAREZ-CUARTIN G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, et al
    Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.
    Respir Med. 2017;128:1-6.
    PubMed     Text format     Abstract available


    June 2017
  49. BLAIS CM, Davis BE, Cockcroft DW
    "Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics" [Respiratory Medicine 118 (September 2016) 96-101].
    Respir Med. 2017 Jun 30. pii: S0954-6111(17)30181.
    PubMed     Text format    


  50. SALEH AD, Chalmers JD, De Soyza A, Fardon TC, et al
    The heterogeneity of systemic inflammation in bronchiectasis.
    Respir Med. 2017;127:33-39.
    PubMed     Text format     Abstract available


  51. PLOURDE A, Lavoie KL, Raddatz C, Bacon SL, et al
    Effects of acute psychological stress induced in laboratory on physiological responses in asthma populations: A systematic review.
    Respir Med. 2017;127:21-32.
    PubMed     Text format     Abstract available


  52. DI MARCO F, Terraneo S, Job S, Rinaldo RF, et al
    Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry.
    Respir Med. 2017;127:7-13.
    PubMed     Text format     Abstract available


  53. LIN J, Li J, Yu W, Liu Y, et al
    A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Respir Med. 2017;127:45-50.
    PubMed     Text format     Abstract available


  54. MACEDO P, Zhang Q, Saito J, Liang Z, et al
    Analysis of bronchial biopsies in chronic cough.
    Respir Med. 2017;127:40-44.
    PubMed     Text format     Abstract available


  55. KONNO S, Makita H, Suzuki M, Shimizu K, et al
    Acute bronchodilator responses to beta2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.
    Respir Med. 2017;127:14-20.
    PubMed     Text format     Abstract available


    May 2017
  56. SCHOR D, Rizzo JA, Medeiros D, Dela Bianca AC, et al
    Home-made spacer as an auxiliary device in administration of beclomethasone via pressurized metered dose inhaler for asthma control. A randomized controlled pragmatic trial.
    Respir Med. 2017;126:52-58.
    PubMed     Text format     Abstract available


  57. BREUER O, Daum H, Cohen-Cymberknoh M, Unger S, et al
    Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.
    Respir Med. 2017;126:39-45.
    PubMed     Text format     Abstract available


  58. NELSEN LM, Kimel M, Murray LT, Ortega H, et al
    Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Respir Med. 2017;126:32-38.
    PubMed     Text format     Abstract available


  59. FERRER GALVAN M, Javier Alvarez Gutierrez F, Romero Falcon A, Romero Romero B, et al
    Is the bronchodilator test an useful tool to measure asthma control?
    Respir Med. 2017;126:26-31.
    PubMed     Text format     Abstract available


  60. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Corrigendum to "Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial" [Respir. Med. 120 (November 2016)
    Respir Med. 2017;126:25.
    PubMed     Text format    


  61. GLOECKL R, Jarosch I, Bengsch U, Claus M, et al
    What's the secret behind the benefits of whole-body vibration training in patients with COPD? A randomized, controlled trial.
    Respir Med. 2017;126:17-24.
    PubMed     Text format     Abstract available


  62. MESQUITA R, Meijer K, Pitta F, Azcuna H, et al
    Changes in physical activity and sedentary behaviour following pulmonary rehabilitation in patients with COPD.
    Respir Med. 2017;126:122-129.
    PubMed     Text format     Abstract available


  63. HANANIA NA, Tashkin DP, Kerwin EM, Donohue JF, et al
    Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension Delivery Technology in patients with chronic obstructive pulmonary disease.
    Respir Med. 2017;126:105-115.
    PubMed     Text format     Abstract available


    April 2017
  64. HAYES D JR, Tumin D, Budev MM, Tobias JD, et al
    Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation.
    Respir Med. 2017 Apr 22. pii: S0954-6111(17)30127.
    PubMed     Text format     Abstract available


  65. NADEAU M, Boulay ME, Milot J, Lepage J, et al
    Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.
    Respir Med. 2017;125:82-88.
    PubMed     Text format     Abstract available


  66. RASTOGI D, Jung M, Strizich G, Shaw PA, et al
    Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults.
    Respir Med. 2017;125:72-81.
    PubMed     Text format     Abstract available


  67. AKIKI Z, Rava M, Diaz Gil O, Pin I, et al
    Serum cytokine profiles as predictors of asthma control in adults from the EGEA study.
    Respir Med. 2017;125:57-64.
    PubMed     Text format     Abstract available


  68. JEONG A, Imboden M, Hansen S, Zemp E, et al
    Heterogeneity of obesity-asthma association disentangled by latent class analysis, the SAPALDIA cohort.
    Respir Med. 2017;125:25-32.
    PubMed     Text format     Abstract available


  69. BODINI R, Santus P, Di Marco F, Aliberti S, et al
    Epidemiology of clinical trials of medicines in respiratory diseases in Europe and Italy.
    Respir Med. 2017;125:8-11.
    PubMed     Text format     Abstract available


  70. DI MARCO F, Santus P, Scichilone N, Solidoro P, et al
    Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Respir Med. 2017;125:49-56.
    PubMed     Text format     Abstract available


  71. D'URZO A, Rennard S, Kerwin E, Donohue JF, et al
    A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease.
    Respir Med. 2017;125:39-48.
    PubMed     Text format     Abstract available


  72. SHIH YN, Chen YT, Chu H, Shih CJ, et al
    Association of pre-hospital theophylline use and mortality in chronic obstructive pulmonary disease patients with sepsis.
    Respir Med. 2017;125:33-38.
    PubMed     Text format     Abstract available


  73. TOTTENBORG SS, Lange P, Thomsen RW, Nielsen H, et al
    Reducing socioeconomic inequalities in COPD care in the hospital outpatient setting - A nationwide initiative.
    Respir Med. 2017;125:19-23.
    PubMed     Text format     Abstract available


  74. HONG JY, Jung JY, Lee MG, Kim SK, et al
    Changes in the prevalence of COPD in Korea between 2001 and 2011 in the KNHANES data.
    Respir Med. 2017;125:12-18.
    PubMed     Text format     Abstract available


    March 2017
  75. DATTA S, Nam HS, Hayashi M, Maldonado L, et al
    Expression of GULP1 in bronchial epithelium is associated with the progression of emphysema in chronic obstructive pulmonary disease.
    Respir Med. 2017;124:72-78.
    PubMed     Text format     Abstract available


  76. TIWARI A, Rahman K, Abejie B, Jain VV, et al
    Longer duration of asthma is significantly associated with increased RV/TLC ratio.
    Respir Med. 2017;124:44-48.
    PubMed     Text format     Abstract available


  77. MANSUR AH, Srivastava S, Mitchell V, Sullivan J, et al
    Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety.
    Respir Med. 2017;124:36-43.
    PubMed     Text format     Abstract available


  78. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    The level of diagnostic assessment in severe asthma: A nationwide real-life study.
    Respir Med. 2017;124:21-29.
    PubMed     Text format     Abstract available


  79. ROGLIANI P, Calzetta L, Coppola A, Cavalli F, et al
    Optimizing drug delivery in COPD: The role of inhaler devices.
    Respir Med. 2017;124:6-14.
    PubMed     Text format     Abstract available


  80. KARDOS P, Vogelmeier C, Worth H, Buhl R, et al
    A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
    Respir Med. 2017;124:57-64.
    PubMed     Text format     Abstract available


    February 2017
  81. SILVERMAN RA, Hasegawa K, Egan DJ, Stiffler KA, et al
    Multicenter study of cigarette smoking among adults with asthma exacerbations in the emergency department, 2011-2012.
    Respir Med. 2017 Feb 7. pii: S0954-6111(17)30025.
    PubMed     Text format     Abstract available


  82. VEIDAL S, Jeppegaard M, Sverrild A, Backer V, et al
    The impact of dysfunctional breathing on the assessment of asthma control.
    Respir Med. 2017;123:42-47.
    PubMed     Text format     Abstract available


  83. BJERREGAARD A, Laing IA, Poulsen N, Backer V, et al
    Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.
    Respir Med. 2017;123:34-41.
    PubMed     Text format     Abstract available


  84. COCKLE SM, Stynes G, Gunsoy NB, Parks D, et al
    Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison.
    Respir Med. 2017;123:140-148.
    PubMed     Text format     Abstract available


  85. VARSANO S, Segev D, Shitrit D
    Severe and non-severe asthma in the community: A large electronic database analysis.
    Respir Med. 2017;123:131-139.
    PubMed     Text format     Abstract available


  86. TAKAKU Y, Kurashima K, Ohta C, Ishiguro T, et al
    How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
    Respir Med. 2017;123:110-115.
    PubMed     Text format     Abstract available


  87. ARMSTRONG HF, Lovasi GS, Soliman EZ, Heckbert SR, et al
    Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.
    Respir Med. 2017;123:1-7.
    PubMed     Text format     Abstract available


  88. BOURBEAU J, Aaron SD, Barnes NC, Davis KJ, et al
    Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.
    Respir Med. 2017;123:94-97.
    PubMed     Text format     Abstract available


  89. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    Chronic bronchitis in relation to hospitalization and mortality over three decades.
    Respir Med. 2017;123:87-93.
    PubMed     Text format     Abstract available


  90. SILER TM, Nagai A, Scott-Wilson CA, Midwinter DA, et al
    A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 mug versus once-daily vilanterol 25 mug to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD.
    Respir Med. 2017;123:8-17.
    PubMed     Text format     Abstract available


  91. OYAMA Y, Enomoto N, Suzuki Y, Kono M, et al
    Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE).
    Respir Med. 2017;123:63-70.
    PubMed     Text format     Abstract available


  92. POMPE E, Galban CJ, Ross BD, Koenderman L, et al
    Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease.
    Respir Med. 2017;123:48-55.
    PubMed     Text format     Abstract available


  93. WANG LY, Zhu YN, Cui JJ, Yin KQ, et al
    Subclinical atherosclerosis risk markers in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2017;123:18-27.
    PubMed     Text format     Abstract available


  94. MELZER AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, et al
    Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD.
    Respir Med. 2017;123:124-130.
    PubMed     Text format     Abstract available


  95. DELLWEG D, Reissig K, Hoehn E, Siemon K, et al
    Inspiratory muscle training during rehabilitation in successfully weaned hypercapnic patients with COPD.
    Respir Med. 2017;123:116-123.
    PubMed     Text format     Abstract available


    January 2017
  96. ADEYEYE OO, Adewumi TA, Adewuya AO
    Effect of psychological and other factors on quality of life amongst asthma outpatients in Lagos, Nigeria.
    Respir Med. 2017;122:67-70.
    PubMed     Text format     Abstract available


  97. HALLIT S, Raherison C, Waked M, Salameh P, et al
    Validation of asthma control questionnaire and risk factors affecting uncontrolled asthma among the Lebanese children's population.
    Respir Med. 2017;122:51-57.
    PubMed     Text format     Abstract available


  98. BUHL R, Magder S, Bothner U, Tetzlaff K, et al
    Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
    Respir Med. 2017;122:58-66.
    PubMed     Text format     Abstract available


  99. LI JX, Fan LC, Li MH, Cao WJ, et al
    Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
    Respir Med. 2017;122:33-42.
    PubMed     Text format     Abstract available


  100. PAULIN FV, Zagatto AM, Chiappa GR, Muller PT, et al
    Addition of vitamin B12 to exercise training improves cycle ergometer endurance in advanced COPD patients: A randomized and controlled study.
    Respir Med. 2017;122:23-29.
    PubMed     Text format     Abstract available


  101. MUELLER S, Wilke T, Bechtel B, Punekar YS, et al
    Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
    Respir Med. 2017;122:1-11.
    PubMed     Text format     Abstract available


    December 2016
  102. CHECKLEY W, Deza MP, Klawitter J, Romero KM, et al
    Identifying biomarkers for asthma diagnosis using targeted metabolomics approaches.
    Respir Med. 2016;121:59-66.
    PubMed     Text format     Abstract available


  103. CHEN JH, Qin L, Shi YY, Feng JT, et al
    IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity.
    Respir Med. 2016;121:48-58.
    PubMed     Text format     Abstract available


  104. MONTEAGUDO M, Rodriguez-Blanco T, Barrecheguren M, Simonet P, et al
    Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study.
    Respir Med. 2016;121:26-31.
    PubMed     Text format     Abstract available


  105. COMARU T, Pitrez PM, Friedrich FO, Silveira VD, et al
    Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil).
    Respir Med. 2016;121:21-25.
    PubMed     Text format     Abstract available


    November 2016
  106. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Respir Med. 2016;120:78-86.
    PubMed     Text format     Abstract available


  107. JANSSON SA, Axelsson M, Hedman L, Leander M, et al
    Subjects with well-controlled asthma have similar health-related quality of life as subjects without asthma.
    Respir Med. 2016;120:64-69.
    PubMed     Text format     Abstract available


  108. DEL GIACCO SR, Cappai A, Gambula L, Cabras S, et al
    The asthma-anxiety connection.
    Respir Med. 2016;120:44-53.
    PubMed     Text format     Abstract available


  109. LAHELMA S, Vahteristo M, Metev H, Taseva M, et al
    Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Respir Med. 2016;120:31-35.
    PubMed     Text format     Abstract available


  110. ALI Z, Nilas L, Ulrik CS
    Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: A case control study.
    Respir Med. 2016;120:124-130.
    PubMed     Text format     Abstract available


  111. APIKOGLU-RABUS S, Yesilyaprak G, Izzettin FV
    Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;120:109-115.
    PubMed     Text format     Abstract available


  112. LARSEN K, Faulkner GE, Boak A, Hamilton HA, et al
    Looking beyond cigarettes: Are Ontario adolescents with asthma less likely to smoke e-cigarettes, marijuana, waterpipes or tobacco cigarettes?
    Respir Med. 2016;120:10-15.
    PubMed     Text format     Abstract available


    October 2016
  113. ANDRIANOPOULOS V, Celli BR, Franssen FM, Pinto-Plata VM, et al
    Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.
    Respir Med. 2016;119:87-95.
    PubMed     Text format     Abstract available


  114. ARFE A, Blasi F, Merlino L, Corrao G, et al
    Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation.
    Respir Med. 2016;119:7-12.
    PubMed     Text format     Abstract available


  115. ENGELKES M, Janssens HM, de Ridder MA, Sturkenboom MC, et al
    Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.
    Respir Med. 2016;119:48-54.
    PubMed     Text format     Abstract available


  116. ZIERAU L, Gade EJ, Lindenberg S, Backer V, et al
    Coexistence of asthma and polycystic ovary syndrome: A concise review.
    Respir Med. 2016;119:155-159.
    PubMed     Text format     Abstract available


  117. SPOSATO B, Scalese M, Latorre M, Scichilone N, et al
    Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.
    Respir Med. 2016;119:141-149.
    PubMed     Text format     Abstract available


  118. BELLELLI G, Chalmers JD, Sotgiu G, Dore S, et al
    Characterization of bronchiectasis in the elderly.
    Respir Med. 2016;119:13-19.
    PubMed     Text format     Abstract available


  119. PETHERICK ES, Pearce N, Sunyer J, Wright J, et al
    Ethnic and socio-economic differences in the prevalence of wheeze, severe wheeze, asthma, eczema and medication usage at 4 years of age: Findings from the Born in Bradford birth cohort.
    Respir Med. 2016;119:122-129.
    PubMed     Text format     Abstract available


  120. BRAITHWAITE I, Williams M, Power S, Pilcher J, et al
    Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Respir Med. 2016;119:115-121.
    PubMed     Text format     Abstract available


  121. OCAL S, Portakal O, Ocal A, Demir AU, et al
    Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects.
    Respir Med. 2016;119:109-114.
    PubMed     Text format     Abstract available


  122. EFTEKHARI P, Forder PM, Majeed T, Byles JE, et al
    Impact of asthma on mortality in older women: An Australian cohort study of 10,413 women.
    Respir Med. 2016;119:102-108.
    PubMed     Text format     Abstract available


  123. MORI K, Fujisawa T, Inui N, Hashimoto D, et al
    Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Respir Med. 2016;119:1-6.
    PubMed     Text format     Abstract available


    September 2016
  124. WESTERHOF GA, de Groot JC, Amelink M, de Nijs SB, et al
    Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma.
    Respir Med. 2016;118:122-7.
    PubMed     Text format     Abstract available


  125. GRZELA K, Litwiniuk M, Krejner A, Zagorska W, et al
    Increased angiogenic factors in exhaled breath condensate of children with severe asthma - New markers of disease progression?
    Respir Med. 2016;118:119-21.
    PubMed     Text format     Abstract available


  126. DAHL R, Engel M, Dusser D, Halpin D, et al
    Safety and tolerability of once-daily tiotropium Respimat((R)) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Respir Med. 2016;118:102-11.
    PubMed     Text format     Abstract available


  127. BLAIS CM, Davis BE, Cockcroft DW
    Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2016;118:96-101.
    PubMed     Text format     Abstract available


  128. KONDLA A, Glaab T, Pedersini R, Lommatzsch M, et al
    Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
    Respir Med. 2016;118:58-64.
    PubMed     Text format     Abstract available


  129. CHAUDHURI R, McSharry C, Heaney LG, Niven R, et al
    Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma.
    Respir Med. 2016;118:46-52.
    PubMed     Text format     Abstract available


  130. SELGE C, Thomas S, Nowak D, Radon K, et al
    Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines.
    Respir Med. 2016;118:15-21.
    PubMed     Text format     Abstract available


  131. SUAREZ-MEDINA R, Venero-Fernandez SJ, Britton J, Fogarty AW, et al
    Population-based weight loss and gain do not explain trends in asthma mortality in Cuba: A prospective study from 1964 to 2014.
    Respir Med. 2016;118:4-6.
    PubMed     Text format     Abstract available


  132. TAN JH, Hsu AA
    Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Respir Med. 2016;118:1-3.
    PubMed     Text format     Abstract available


    August 2016
  133. MATULONGA B, Rava M, Siroux V, Bernard A, et al
    Women using bleach for home cleaning are at increased risk of non-allergic asthma.
    Respir Med. 2016;117:264-71.
    PubMed     Text format     Abstract available


  134. BECERRA MB, Becerra BJ, Teodorescu M
    Healthcare burden of obstructive sleep apnea and obesity among asthma hospitalizations: Results from the U.S.-based Nationwide Inpatient Sample.
    Respir Med. 2016;117:230-6.
    PubMed     Text format     Abstract available


  135. TUOMISTO LE, Ilmarinen P, Niemela O, Haanpaa J, et al
    A 12-year prognosis of adult-onset asthma: Seinajoki Adult Asthma Study.
    Respir Med. 2016;117:223-9.
    PubMed     Text format     Abstract available


  136. CRISAFULLI E, Alfieri V, Silva M, Aiello M, et al
    Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients.
    Respir Med. 2016;117:207-14.
    PubMed     Text format     Abstract available


  137. KERSTJENS HA, Moroni-Zentgraf P, Tashkin DP, Dahl R, et al
    Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
    Respir Med. 2016;117:198-206.
    PubMed     Text format     Abstract available


  138. WILSON R, Aksamit T, Aliberti S, De Soyza A, et al
    Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.
    Respir Med. 2016;117:179-89.
    PubMed     Text format     Abstract available


  139. RADHAKRISHNA N, Tay TR, Hore-Lacy F, Hoy R, et al
    Profile of difficult to treat asthma patients referred for systematic assessment.
    Respir Med. 2016;117:166-73.
    PubMed     Text format     Abstract available


  140. NAQVI M, Khachi H
    The barriers to accessing primary care resulting in hospital presentation for exacerbation of asthma or chronic obstructive pulmonary disease in a large teaching hospital in London.
    Respir Med. 2016;117:162-5.
    PubMed     Text format     Abstract available


  141. LICCARDI G, Salzillo A, Calzetta L, Cazzola M, et al
    Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics.
    Respir Med. 2016;117:150-3.
    PubMed     Text format     Abstract available


  142. GORSKA K, Korczynski P, Mierzejewski M, Kosciuch J, et al
    Comparison of endobronchial ultrasound and high resolution computed tomography as tools for airway wall imaging in asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;117:131-8.
    PubMed     Text format     Abstract available


  143. VERMEULEN F, Garcia G, Ninane V, Laveneziana P, et al
    Activity limitation and exertional dyspnea in adult asthmatic patients: What do we know?
    Respir Med. 2016;117:122-30.
    PubMed     Text format     Abstract available


  144. HARTMAN JE, Klooster K, Slebos DJ, Ten Hacken NH, et al
    Improvement of physical activity after endobronchial valve treatment in emphysema patients.
    Respir Med. 2016;117:116-21.
    PubMed     Text format     Abstract available


  145. KOSKELA HO, Purokivi MK, Kokkarinen J
    Stepping down from combination asthma therapy: The predictors of outcome.
    Respir Med. 2016;117:109-15.
    PubMed     Text format     Abstract available


  146. KJELLBERG S, Houltz BK, Zetterstrom O, Robinson PD, et al
    Clinical characteristics of adult asthma associated with small airway dysfunction.
    Respir Med. 2016;117:92-102.
    PubMed     Text format     Abstract available


  147. PAPAIOANNOU AI, Kostikas K, Manali ED, Papadaki G, et al
    Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.
    Respir Med. 2016;117:14-26.
    PubMed     Text format     Abstract available


    July 2016
  148. SUAREZ-CUARTIN G, Chalmers JD, Sibila O
    Diagnostic challenges of bronchiectasis.
    Respir Med. 2016;116:70-7.
    PubMed     Text format     Abstract available


  149. MIRABELLI MC, Hsu J, Gower WA
    Comorbidities of asthma in U.S. children.
    Respir Med. 2016;116:34-40.
    PubMed     Text format     Abstract available


  150. USMANI OS, Singh D, Spinola M, Bizzi A, et al
    The prevalence of small airways disease in adult asthma: A systematic literature review.
    Respir Med. 2016;116:19-27.
    PubMed     Text format     Abstract available


  151. DIMAKOU K, Triantafillidou C, Toumbis M, Tsikritsaki K, et al
    Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.
    Respir Med. 2016;116:1-7.
    PubMed     Text format     Abstract available


    June 2016
  152. RADEMACHER J, Ringshausen FC, Suhling H, Fuge J, et al
    Lung transplantation for non-cystic fibrosis bronchiectasis.
    Respir Med. 2016;115:60-5.
    PubMed     Text format     Abstract available


  153. BUHL R, Korn S, Menzies-Gow A, Aubier M, et al
    Assessing biomarkers in a real-world severe asthma study (ARIETTA).
    Respir Med. 2016;115:7-12.
    PubMed     Text format     Abstract available


  154. OHRMALM L, Malinovschi A, Wong M, Levinson P, et al
    Presence of rhinovirus in the respiratory tract of adolescents and young adults with asthma without symptoms of infection.
    Respir Med. 2016;115:1-6.
    PubMed     Text format     Abstract available


    May 2016
  155. HEFFLER E, Crimi N
    Asthma control and bronchodilator response.
    Respir Med. 2016 May 15. pii: S0954-6111(16)30096.
    PubMed     Text format    


  156. RAJAURE Y, Kumar B, Sahoo K, T V, et al
    Bronchodilator response not a significant marker of poor asthma control.
    Respir Med. 2016 May 10. pii: S0954-6111(16)30076.
    PubMed     Text format    


    April 2016
  157. PATEL MS, Donaldson AV, Lewis A, Natanek SA, et al
    Klotho and smoking--An interplay influencing the skeletal muscle function deficits that occur in COPD.
    Respir Med. 2016;113:50-6.
    PubMed     Text format     Abstract available


  158. JACOB R, Bentur L, Brik R, Shavit I, et al
    Is capnometry helpful in children with bronchiolitis?
    Respir Med. 2016;113:37-41.
    PubMed     Text format     Abstract available


  159. SPIELMANNS M, Gloeckl R, Schmoor C, Windisch W, et al
    Effects on pulmonary rehabilitation in patients with COPD or ILD: A retrospective analysis of clinical and functional predictors with particular emphasis on gender.
    Respir Med. 2016;113:8-14.
    PubMed     Text format     Abstract available


  160. RODRIGUE C, Beauchesne MF, Savaria F, Forget A, et al
    Adverse events among COPD patients treated with long-acting anticholinergics and beta2-agonists in an outpatient respiratory clinic.
    Respir Med. 2016;113:65-73.
    PubMed     Text format     Abstract available


    March 2016
  161. RUTTEN EP
    Comment on "Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study".
    Respir Med. 2016;112:130.
    PubMed     Text format    


  162. HUSSEIN SH, Nielsen LP, Dolberg MK, Dahl R, et al
    Response to Dr. Rutten's comment on "Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study".
    Respir Med. 2016;112:131.
    PubMed     Text format    


  163. WELTE T, Chapman KR, Magnussen H, Miravitlles M, et al
    Current thinking and new paradigm for COPD.
    Respir Med. 2016;112:126-7.
    PubMed     Text format     Abstract available


  164. ONATIBIA-ASTIBIA A, Martinez-Pinilla E, Franco R
    The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.
    Respir Med. 2016;112:1-9.
    PubMed     Text format     Abstract available


  165. GREEN CE, Parr DG, Edgar RG, Stockley RA, et al
    Lung density associates with survival in alpha 1 antitrypsin deficient patients.
    Respir Med. 2016;112:81-7.
    PubMed     Text format     Abstract available


  166. DISANTOSTEFANO RL, Hinds D, Le HV, Barnes NC, et al
    Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort.
    Respir Med. 2016;112:88-96.
    PubMed     Text format     Abstract available


  167. NIN CS, de Souza VV, do Amaral RH, Schuhmacher Neto R, et al
    Thoracic lymphadenopathy in benign diseases: A state of the art review.
    Respir Med. 2016;112:10-7.
    PubMed     Text format     Abstract available


  168. DONOHUE JF, Singh D, Munzu C, Kilbride S, et al
    Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials.
    Respir Med. 2016;112:65-74.
    PubMed     Text format     Abstract available


    February 2016
  169. WORTH H, Buhl R, Criee CP, Kardos P, et al
    The 'real-life' COPD patient in Germany: The DACCORD study.
    Respir Med. 2016;111:64-71.
    PubMed     Text format     Abstract available


  170. BARRECHEGUREN M, Monteagudo M, Ferrer J, Borrell E, et al
    Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study.
    Respir Med. 2016;111:47-53.
    PubMed     Text format     Abstract available


  171. ROBERTS NJ, Patel IS, Partridge MR
    The diagnosis of COPD in primary care; gender differences and the role of spirometry.
    Respir Med. 2016;111:60-3.
    PubMed     Text format     Abstract available


  172. WACKER ME, Jorres RA, Schulz H, Heinrich J, et al
    Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study.
    Respir Med. 2016;111:39-46.
    PubMed     Text format     Abstract available


  173. CHECKLEY W, Foreman MG, Bhatt SP, Dransfield MT, et al
    Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
    Respir Med. 2016;111:30-8.
    PubMed     Text format     Abstract available


    January 2016
  174. BOLAND MR, van Boven JF, Kruis AL, Chavannes NH, et al
    Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence.
    Respir Med. 2016;110:34-45.
    PubMed     Text format     Abstract available


  175. PRINS HJ, Daniels JM, Lindeman JH, Lutter R, et al
    Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial.
    Respir Med. 2016;110:46-52.
    PubMed     Text format     Abstract available


  176. MAIO S, Baldacci S, Carrozzi L, Pistelli F, et al
    Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study.
    Respir Med. 2016;110:58-65.
    PubMed     Text format     Abstract available


  177. JARENBACK L, Ankerst J, Bjermer L, Tufvesson E, et al
    Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.
    Respir Med. 2016;110:28-33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: